Showing it’s not just genes that get promoted, we congratulate two of our research leaders for their promotion as UNSW academics, a tribute to their significant research achievements.

Dr Tao Liu has been appointed to the position of Associate Professor, effective 1 January 2017, through a rigorous academic application process.

This is a reflection of Tao’s significant and successful record of achievement in consistently attracting NHMRC and other grant funding, his frequent and high quality research publications, supervision of students and broader contributions to the University and medical research sector.

Tao heads up our Histone Modification group, leading a team of researchers studying cell proteins called histones which are the main protein components of chromatin, acting as spools for DNA to wind around and playing a role in gene regulation. Cancer cells chemically modify histones to ‘switch off’ the transcription of genes that help suppress tumour initiation and progression, and ‘switch on’ the transcription of genes that induce these processes. Tao’s group is focused on understanding altered gene transcription in cancer with the goal to improve anti-cancer therapies.

Dr David Ziegler

Dr David Ziegler has also been promoted to Conjoint Associate Professor at UNSW. David is an outstanding clinician scientist, combining clinical leadership of national and international early phase clinical trials at the Kids Cancer Centre at Sydney Children’s Hospital, Randwick with leadership of a flourishing research group at Children’s Cancer Institute.

David Ziegler

David leads the Targeted Therapy research group which is developing innovative therapies for brain cancers, particularly Diffuse Instrinsic Pontine Glioma (DIPG), one of the most aggressive and devastating childhood cancers.

David has grown his research team and supported their important research by attracting substantial NHMRC and other peer-reviewed grant funding, as well as philanthropic support. His commitment to supporting high quality translational research, including his key role in the Zero Childhood Cancer personalised medicine program, led jointly by Children’s Cancer Institute and Kids Cancer Centre at Sydney Children’s Hospital, Randwick, is a major contributor to the Institute’s research achievements.

Read more about the work of Drs (soon to be A/Profs) Liu and Ziegler. Congratulations to both research leaders!

Send this to a friend